EP1227841A4 - Nouveau procede permettant de diagnostiquer, surveiller, determiner le stade, imager et traiter un cancer - Google Patents

Nouveau procede permettant de diagnostiquer, surveiller, determiner le stade, imager et traiter un cancer

Info

Publication number
EP1227841A4
EP1227841A4 EP00975587A EP00975587A EP1227841A4 EP 1227841 A4 EP1227841 A4 EP 1227841A4 EP 00975587 A EP00975587 A EP 00975587A EP 00975587 A EP00975587 A EP 00975587A EP 1227841 A4 EP1227841 A4 EP 1227841A4
Authority
EP
European Patent Office
Prior art keywords
staging
diagnosing
imaging
monitoring
treating cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00975587A
Other languages
German (de)
English (en)
Other versions
EP1227841A1 (fr
Inventor
Herve Recipon
Roberto A Macina
Sei-Yu Chen
Yongming Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Diadexus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc filed Critical Diadexus Inc
Publication of EP1227841A1 publication Critical patent/EP1227841A1/fr
Publication of EP1227841A4 publication Critical patent/EP1227841A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1054—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3023—Lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Optics & Photonics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP00975587A 1999-11-04 2000-11-03 Nouveau procede permettant de diagnostiquer, surveiller, determiner le stade, imager et traiter un cancer Withdrawn EP1227841A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16344499P 1999-11-04 1999-11-04
US163444P 1999-11-04
PCT/US2000/030482 WO2001032209A1 (fr) 1999-11-04 2000-11-03 Nouveau procede permettant de diagnostiquer, surveiller, determiner le stade, imager et traiter un cancer

Publications (2)

Publication Number Publication Date
EP1227841A1 EP1227841A1 (fr) 2002-08-07
EP1227841A4 true EP1227841A4 (fr) 2003-01-22

Family

ID=22590029

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00975587A Withdrawn EP1227841A4 (fr) 1999-11-04 2000-11-03 Nouveau procede permettant de diagnostiquer, surveiller, determiner le stade, imager et traiter un cancer

Country Status (4)

Country Link
EP (1) EP1227841A4 (fr)
JP (2) JP3524536B2 (fr)
CA (1) CA2389964A1 (fr)
WO (1) WO2001032209A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902890B1 (en) 1999-11-04 2005-06-07 Diadexus, Inc. Method of diagnosing monitoring, staging, imaging and treating cancer
CN112365948B (zh) * 2020-10-27 2023-07-18 沈阳东软智能医疗科技研究院有限公司 癌症分期预测系统

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747264A (en) * 1996-08-02 1998-05-05 Smithkline Beechum Corporation Method of diagnosing and monitoring prostate cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747264A (en) * 1996-08-02 1998-05-05 Smithkline Beechum Corporation Method of diagnosing and monitoring prostate cancer

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CHARPENTIER APRIL H ET AL: "STC2 and E2IG1, two novel breast cancer biomarkers.", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL, vol. 42, March 2001 (2001-03-01), 92nd Annual Meeting of the American Association for Cancer Research;New Orleans, LA, USA; March 24-28, 2001, March, 2001, pages 628, XP001119829, ISSN: 0197-016X *
CHEN SEIYU ET AL: "Evidences of human stanniocalcin 1 and amino acid transporter ATB0+ as potential diagnostic marker for non-small cell lung cancer.", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL, vol. 43, March 2002 (2002-03-01), 93rd Annual Meeting of the American Association for Cancer Research;San Francisco, California, USA; April 06-10, 2002, March, 2002, pages 518 - 519, XP001119830, ISSN: 0197-016X *
KAHN JEANNE ET AL: "Gene expression profiling in an in vitro model of angiogenesis", AMERICAN JOURNAL OF PATHOLOGY, PHILADELPHIA, PA, US, vol. 156, no. 6, June 2000 (2000-06-01), pages 1887 - 1900, XP002178225, ISSN: 0002-9440 *
LIANG P ET AL: "DIFFERENTIAL DISPLAY OF EUKARYOTIC MESSENGER RNA BY MEANS OF THE POLYMERASE CHAIN REACTION", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 257, no. 5072, 14 August 1992 (1992-08-14), pages 967 - 971, XP000508268, ISSN: 0036-8075 *
PENG LIANG ET AL: "DIFFERENTIAL DISPLAY AND CLONING OF MESSENGER RNAS FROM HUMAN BREAST CANCER VERSUS MAMMARY EPITHELIAL CELLS", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 52, 15 December 1992 (1992-12-15), pages 6966 - 6968, XP002032010, ISSN: 0008-5472 *
See also references of WO0132209A1 *

Also Published As

Publication number Publication date
JP3524536B2 (ja) 2004-05-10
CA2389964A1 (fr) 2001-05-10
JP2003513254A (ja) 2003-04-08
WO2001032209A1 (fr) 2001-05-10
JP2004170428A (ja) 2004-06-17
EP1227841A1 (fr) 2002-08-07

Similar Documents

Publication Publication Date Title
EP1105528A4 (fr) Nouvelle methode permettant de diagnostiquer, de surveiller le cancer du sein, d'en determiner le stade ainsi que d'en former des images et de le traiter
EP1239874A4 (fr) Methode de diagnostic, de controle, de stadification, d'imagerie et de traitement du cancer de la prostate
EP1082459A4 (fr) Technique de diagnostic, de suivi et de stadification du cancer du poumon
MXPA01008794A (es) Metodo para diagnosticar y verificar carcinomas de pecho malignos.
IL142729A0 (en) Method for improved imaging and photodynamic therapy
EP1408820A4 (fr) Capsule et procede de traitement ou de diagnostic du tractus intestinal
EP1131095A4 (fr) Methode permettant de diagnostiquer, de surveiller, de classer par stades, de visualiser et de traiter le cancer de la prostate
EP1146912A4 (fr) Procedes et agents destines a une radiotherapie amelioree
EP1267934A4 (fr) Nouvelle methode de diagnostic, de surveillance, de stadification, d'imagerie et de traitement du cancer du sein
AU2001250932A8 (en) Compositions and methods of diagnosing, monitoring, staging, imaging and treating prostate cancer
IL128531A0 (en) Method for treating heart failure
AU2001251223A1 (en) Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer
EP1107798A4 (fr) Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer du colon
EP1104486A4 (fr) Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons
AU2001268633A1 (en) Method of diagnosing, monitoring, staging, imaging and treating breast cancer
GB9820919D0 (en) Diagnostic method
EP1082460A4 (fr) Nouveau procede de diagnostic, de surveillance et de stadification du cancer de la prostate
AU2001271621A1 (en) Method of diagnosing, monitoring, staging, imaging and treating colon cancer
AU2001241656A1 (en) Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
EP1117833A4 (fr) Nouveau procede pour diagnostiquer, surveiller, etablir la stadification, obtenir des images et traiter des cancers gastro-intestinaux
EP1126877A4 (fr) Methode de diagnostic, de suivi, de classification par stade, de visualisation et de traitement de cancer de la prostate
NO20014805L (no) Blandinger og fremgangsmater for behandling og diagnose av brystkreft
EP1227841A4 (fr) Nouveau procede permettant de diagnostiquer, surveiller, determiner le stade, imager et traiter un cancer
EP1250149A4 (fr) Nouvelle methode de diagnostic, de suivi, de stadification, d'imagerie et de traitement du cancer
AU6523901A (en) Method of diagnosing, monitoring, staging, imaging and treating colon cancer

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020531

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

A4 Supplementary search report drawn up and despatched

Effective date: 20021206

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 39/395 A, 7A 61K 39/40 B, 7A 61K 39/42 B, 7A 61K 39/44 B, 7A 61K 39/00 B, 7A 61K 39/38 B, 7A 61K 38/00 B, 7C 12N 5/06 B, 7C 12N 5/16 B, 7C 12Q 1/68 B, 7C 07K 16/30 B, 7A 61K 49/16 B, 7A 61K 51/10 B

17Q First examination report despatched

Effective date: 20030407

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050429